Structure via PubChem · Public domain (PubChem)
zopiclone
Sign in to saveAlso known as RP-27267, Zimovane®, 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate, (±)-zopiclone
Key facts
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458773669
- Drug.IUPAC_name
- (RS)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
- Drug.image
- Zopiclone structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200
- Drug.caption
- Above: molecular structure of zopiclone Below: 3D representation of the (S)-zopiclone molecule
- Drug.image2
- Zopiclone 3D.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 230
- Drug.tradename
- Imovane, Zimovane, Dopareel, others
- Drug.pregnancy_AU
- C
- Drug.legal_AU
- S4
- Drug.dependency_liability
- High
- Drug.routes_of_administration
- Oral tablets, 3.75 mg or 7.5mg (UK), 5 mg, 7.5 mg, or 10 mg (JP)
- Drug.bioavailability
- 75–80%
- Drug.protein_bound
- 52–59%
- Drug.metabolism
- Hepatic through CYP3A4 and CYP2E1
via Wikipedia infobox
Chemical data
- Formula
- C17H17ClN6O3
- Molecular weight
- 388.8 g/mol
- IUPAC name
- [6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
- SMILES
- CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
- InChIKey
- GBBSUAFBMRNDJC-UHFFFAOYSA-N
- XLogP
- 0.5
- Polar surface area
- 91.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Research
1,580 papers- Zopiclone to treat insomnia in older adults: A systematic review.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.Lancet (London, England) · 2022
- Zopiclone induced methemoglobinemia and hemolytic anemia.International journal of clinical pharmacology and therapeutics · 2014
- Zopiclone: is there any dependence and abuse potential?Journal of neurology · 1997
- Zopiclone as a Potent Positive Control for Assessing the Residual Effects of Hypnotic Drugs on Next Day Driving Performance: A Systematic Review.Human psychopharmacology · 2025
via PubMed
Wikidata facts
- Mass
- 388.105066
Show 5 more facts
- chemical formula
- C₁₇H₁₇ClN₆O₃
- defined daily dose
- 7.5
- Commons category
- Zopiclone
- canonical SMILES
- CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
- World Health Organisation international non-proprietary name
- zopiclone
Sources (8)
via Wikidata · CC0
~19 min read
Article
18 sectionsContents
- Medical uses
- Specific populations
- Elderly
- Liver disease
- Adverse reactions
- Contraindications
- EEG and sleep
- Overdose
- Interactions
- Pharmacology
- Pharmacokinetics
- Chemistry
- Detection in biological fluids
- History
- Society and culture
- Recreational use
- References
- External links
Zopiclone, sold under the brand name Imovane among others, is a nonbenzodiazepine, specifically a cyclopyrrolone, used to treat insomnia. While molecularly distinct from benzodiazepine drugs, Zopiclone's mechanism of action is similar; it increases the normal transmission of the neurotransmitter gamma-aminobutyric acid (GABA) in the central nervous system, via positive allosteric modulation at GABAA neurons.
Zopiclone is considered a sedative and CNS depressant. After prolonged use, the body can become accustomed to the effects of zopiclone. When the dose is then reduced or the drug is abruptly stopped, withdrawal symptoms may result. These can include a range of symptoms similar to those of benzodiazepine withdrawal. Although withdrawal symptoms from therapeutic doses of zopiclone and its isomers (i.e., eszopiclone) do not typically present with convulsions and are therefore not considered life-threatening, patients may experience such significant agitation or anxiety that they seek emergency medical attention.